000 01473 a2200373 4500
005 20250517195501.0
264 0 _c20180917
008 201809s 0 0 eng d
022 _a1535-2900
024 7 _a10.2146/ajhp170160
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWilson, David M
245 0 0 _aPharmacokinetics, safety, and patient acceptability of subcutaneous versus intramuscular testosterone injection for gender-affirming therapy: A pilot study.
_h[electronic resource]
260 _bAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
_c03 2018
300 _a351-358 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aCross-Over Studies
650 0 4 _aDrug Tolerance
650 0 4 _aHumans
650 0 4 _aInjections, Intramuscular
650 0 4 _aInjections, Subcutaneous
650 0 4 _aMale
650 0 4 _aPatient Safety
650 0 4 _aPilot Projects
650 0 4 _aProspective Studies
650 0 4 _aTestosterone
_xadministration & dosage
650 0 4 _aTransgender Persons
650 0 4 _aYoung Adult
700 1 _aKiang, Tony K L
700 1 _aEnsom, Mary H H
773 0 _tAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
_gvol. 75
_gno. 6
_gp. 351-358
856 4 0 _uhttps://doi.org/10.2146/ajhp170160
_zAvailable from publisher's website
999 _c28011691
_d28011691